Patient engagement and self-management in pulmonary arterial hypertension

Jytte Graarup, Pisana Ferrari, Luke S. Howard

Source: Eur Respir Rev 2016; 25: 399-407
Journal Issue: December
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jytte Graarup, Pisana Ferrari, Luke S. Howard. Patient engagement and self-management in pulmonary arterial hypertension. Eur Respir Rev 2016; 25: 399-407

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Patient perspectives on exercise training in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014



Optimising the management of pulmonary arterial hypertension patients: emergency treatments
Source: Eur Respir Rev 2010 19: 204-211
Year: 2010



Pulmonary rehabilitation in patients with pulmonary arterial hypertension
Source: ERS Course 2017
Year: 2017

Physician/patient reporting of depression/anxiety in a US pulmonary arterial hypertension population
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Improving patient outcomes in pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 550-551
Year: 2015


Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012



Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Current medical treatment of pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Current medical treatment of pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Improving survival in pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 218-220
Year: 2005


Exercise training in pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 641s
Year: 2006

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



Predictors of physical activity in pulmonary arterial and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019




Psychometric validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019